These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6770287)

  • 61. Enzymatic defects in porphyria: an overview.
    Elder GH
    Semin Liver Dis; 1982 May; 2(2):87-99. PubMed ID: 6753167
    [No Abstract]   [Full Text] [Related]  

  • 62. [Acute intermittent porphyria in pregnancy: glucose or hematin therapy?].
    Isenschmid M; König C; Fässli C; Haenel A; Hänggi W; Schneider H
    Schweiz Med Wochenschr; 1992 Nov; 122(46):1741-5. PubMed ID: 1448679
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 17-Oxosteroid conjugates in plasma and urine of patients with acute intermittent porphyria.
    Paxton JW; Moore MR; Deattie AD; Goldberg A
    Clin Sci Mol Med; 1974 Feb; 46(2):207-22. PubMed ID: 4817273
    [No Abstract]   [Full Text] [Related]  

  • 64. Haematin therapy and leucocyte delta-aminolevulinic-acid-synthase activity in prolonged attack of acute porphyria.
    McColl KE; Thompson GT; Moore MR; Goldberg A
    Lancet; 1979 Jan; 1(8108):133-4. PubMed ID: 84154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage.
    Lelli SM; Mazzetti MB; San Martín de Viale LC
    Biochem Pharmacol; 2008 Feb; 75(3):704-12. PubMed ID: 17996218
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Porphyrinogenic effects of atracurium, vecuronium, and pancuronium in a primed rat model.
    Böhrer H; Schmidt H; Bach A; Martin E; Kohl B; Bolsen K; Goerz G
    Lab Anim Sci; 1994 Aug; 44(4):326-30. PubMed ID: 7983842
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sodium valproate and clonazepam for epilepsy.
    Drug Ther Bull; 1975 Dec; 13(25):97-8. PubMed ID: 1104300
    [No Abstract]   [Full Text] [Related]  

  • 68. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
    Tasnádi G; Bor M; Pusztai A
    Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathogenesis and treatment of acute intermittent porphyria: discussion paper.
    Laiwah AC; Goldberg A; Moore MR
    J R Soc Med; 1983 May; 76(5):386-92. PubMed ID: 6864706
    [No Abstract]   [Full Text] [Related]  

  • 70. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
    Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Porphyria--biochemical background, clinical aspects and diagnosis].
    Wennersten G
    Lakartidningen; 1979 Dec; 76(52):4792-7. PubMed ID: 397384
    [No Abstract]   [Full Text] [Related]  

  • 72. Cadmium as an inducer of chemical porphyria in chick embryo.
    Prasad AR; Shanker J; Datta K
    Indian J Exp Biol; 1985 Jul; 23(7):361-2. PubMed ID: 4077133
    [No Abstract]   [Full Text] [Related]  

  • 73. Enzymes in the hepatic porphyrias.
    Lancet; 1972 Jul; 2(7768):121. PubMed ID: 4113898
    [No Abstract]   [Full Text] [Related]  

  • 74. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of hematin in acute porphyric relapse].
    Monsalve V; Wolff C; Gómez R; Armas Merino R; Canals C
    Rev Med Chil; 1979 Jan; 107(1):38-41. PubMed ID: 462025
    [No Abstract]   [Full Text] [Related]  

  • 76. Alcohol and porphyrin metabolism.
    Doss MO; Kühnel A; Gross U
    Alcohol Alcohol; 2000; 35(2):109-25. PubMed ID: 10787385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute intermittent porphyria.
    O'Connor LJ
    Am J Nurs; 1981 Jun; 81(6):1184-6. PubMed ID: 6909012
    [No Abstract]   [Full Text] [Related]  

  • 78. Porphyria in relation to surgery and anaesthesia.
    Sumner E
    Ann R Coll Surg Engl; 1975 Feb; 56(2):81-8. PubMed ID: 1119785
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Drug risk of hepatic porphyria. Development of an animal experiment model].
    Deybach JC; Da Silva V; Phung LN; Levy JC; Nordmann Y
    Presse Med; 1987 Jan; 16(2):68-71. PubMed ID: 2949310
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity.
    Hift RJ; Thunell S; Brun A
    Pharmacol Ther; 2011 Nov; 132(2):158-69. PubMed ID: 21704073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.